enkephalin, leucine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, A; Casalboni, S; Cennamo, E; Cusani, V; De Magistris, A; De Marco, F; Del Sasso, A; Di Somma, S; Gaudio, M; Hartmann, O; Marin, D; Ndogmo Beumo, B; Papasidero, ID; Rocchi, R; Ruggieri, MP; Valli, G | 1 |
| Beaudry, F; Boudrias, J; Clémencin, R; Eysseric, E; Guérette, C; Guillaumain, C; Moreau, M; Segura, PA | 1 |
2 other study(ies) available for enkephalin, leucine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department.
Topics: Adrenomedullin; Biomarkers; COVID-19; Emergency Service, Hospital; Enkephalins; Humans; Lung Diseases, Interstitial; Prognosis | 2022 |
Ultrafast analysis of peptides by laser diode thermal desorption-triple quadrupole mass spectrometry.
Topics: COVID-19; Enkephalin, Leucine; Humans; Ions; Lasers; Pandemics; Peptides; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tandem Mass Spectrometry | 2022 |